Context Therapeutics annual net debt
2021
2022
2023
2024
2025
Context Therapeutics Net Debt Growth & History (CNTX)
Context Therapeutics's net debt was −$65.9M for fiscal 2025.
View full Context Therapeutics company overviewContext Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$65.9M | $28.3M | — |
| 2024 | 2024-12-31 | −$94.2M | −$79.8M | — |
| 2023 | 2023-12-31 | −$14.4M | $21.0M | — |
| 2022 | 2022-12-31 | −$35.4M | $14.2M | — |
| 2021 | 2021-12-31 | −$49.6M | — | — |
Context Therapeutics quarterly net debt
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$42.8M | $40.5M | — |
| Q1 2026 | 2026-03-31 | −$54.2M | $34.9M | — |
| Q4 2025 | 2025-12-31 | −$65.9M | $28.3M | — |
| Q3 2025 | 2025-09-30 | −$76.8M | $7.8M | — |
| Q2 2025 | 2025-06-30 | −$83.3M | $18.2M | — |
| Q1 2025 | 2025-03-31 | −$89.2M | −$79.1M | — |
| Q4 2024 | 2024-12-31 | −$94.2M | −$79.8M | — |
| Q3 2024 | 2024-09-30 | −$84.6M | −$62.9M | — |
| Q2 2024 | 2024-06-30 | −$101.5M | −$76.4M | — |
| Q1 2024 | 2024-03-31 | −$10.1M | $19.6M | — |
| Q4 2023 | 2023-12-31 | −$14.4M | $21.0M | — |
| Q3 2023 | 2023-09-30 | −$21.7M | $17.7M | — |
| Q2 2023 | 2023-06-30 | −$25.1M | $17.7M | — |
| Q1 2023 | 2023-03-31 | −$29.7M | $15.9M | — |
| Q4 2022 | 2022-12-31 | −$35.4M | $14.2M | — |
| Q3 2022 | 2022-09-30 | −$39.3M | — | — |
| Q2 2022 | 2022-06-30 | −$42.8M | — | — |
| Q1 2022 | 2022-03-31 | −$45.6M | — | — |
| Q4 2021 | 2021-12-31 | −$49.6M | — | — |
Context Therapeutics net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Context Therapeutics's net debt decreased from −$49.6M to −$65.9M, a change of −$16.3M. The latest reported quarter, Q2 2026, shows −$42.8M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Context Therapeutics source filings ↗